| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(03)02106-X |
| P698 | PubMed publication ID | 12954372 |
| P2093 | author name string | Carlos M Villalón | |
| Mercedes Perusquía | |||
| Gregorio Pérez-Palacios | |||
| Ana E Lemus | |||
| Erika Navarrete | |||
| Gustavo A García | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency | Q28240617 | ||
| Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites | Q28306011 | ||
| The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP | Q28344628 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms | Q31955778 | ||
| Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells | Q32000800 | ||
| Progestins and cardiovascular risk markers | Q34100036 | ||
| Hormone therapy to prevent disease and prolong life in postmenopausal women | Q34262585 | ||
| Nongenomic action of steroids in myometrial contractility | Q34381521 | ||
| Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids | Q37857707 | ||
| 17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line | Q41475091 | ||
| Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). | Q42679385 | ||
| Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at term | Q43644408 | ||
| Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation | Q43805283 | ||
| The vasodepressor effect of androgens in pithed rats: potential role of calcium channels | Q44222354 | ||
| Properties of a progesterone-induced relaxation in human placental arteries and veins | Q45085183 | ||
| Evidence that a non-aromatizable metabolite of norethisterone induces estrogen-dependent pituitary progestin receptors | Q48380966 | ||
| Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro | Q50795554 | ||
| Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. | Q52394286 | ||
| Possible role of Ca2+ channels in the vasodilating effect of 5beta-dihydrotestosterone in rat aorta. | Q54093590 | ||
| Steroids. LIV.1Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone2 | Q55953222 | ||
| Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood | Q67564498 | ||
| Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women | Q67576081 | ||
| Hormone replacement therapy and cardiovascular disease | Q67592974 | ||
| Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta | Q71351387 | ||
| Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease | Q71505808 | ||
| Norethisterone metabolites modulate the uteroglobin and progesterone receptor gene expression in prepubertal rabbits | Q72143605 | ||
| Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys | Q72811876 | ||
| Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites | Q73012759 | ||
| Estrogens, progestins and coronary artery reactivity | Q73122348 | ||
| Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm | Q73122425 | ||
| Temporal changes in clinic and ambulatory blood pressure during cyclic post-menopausal hormone replacement therapy | Q73138313 | ||
| Nomegestrol acetate and vascular reactivity: nonhuman primate experiments | Q73276073 | ||
| Vascular Effects of Progesterone : Role of Cellular Calcium Regulation | Q73513442 | ||
| Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate | Q73584187 | ||
| Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins | Q74379872 | ||
| The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane | Q74561287 | ||
| Hormone replacement therapy | Q77088378 | ||
| Antagonistic effects of 17 beta-estradiol, progesterone, and testosterone on Ca2+ entry mechanisms of coronary vasoconstriction | Q77297673 | ||
| Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis) | Q77580502 | ||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 161-9 | |
| P577 | publication date | 2003-08-15 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Vasodilating effect of norethisterone and its 5 alpha metabolites: a novel nongenomic action | |
| P478 | volume | 475 |
| Q37608577 | Hormone therapy and cardiovascular risk markers and disease: focus on progestagens | cites work | P2860 |
Search more.